< Ruth Ley wird mit dem Ernst Jung-Preis für Medizin 2018 ausgezeichnet
04.05.2018 By: Martin Vötsch

Ruth Ley receives the Ernst Jung-Prize for Medicine 2018

Tübingen, May 4th, 2018. The Jung Foundation for Science and Research in Hamburg announced that the Ernst Jung Prize for Medicine 2018 will be shared by Prof. Dr. Ruth Ley, Director of the Department of Microbiome Science at the Max Planck Institute for Developmental Biology in Tübingen and Prof. Dr. med. Marco Prinz from the University Hospital Freiburg. Ruth Ley is recognized for her contributions to the field of intestinal microbiome research, as well as the interaction between nutrition, the host and gut microbiota.  The award, which includes a prize of 150,000 Euro, will be presented at a ceremony on May 4th, 2018 in Hamburg.


The Ernst Jung Prize for Medicine was established by Ernst Jung (1896-1976), a Hamburg-based shipping magnate. Since 1976, the Jung Foundation for Science and Research annually recognizes groundbreaking research in medicine and basic research. The foundation also conferss the Ernst Jung Medal to honor the lifetime achievement of scientists in medicine, and the Ernst Jung Career Promotion Prize for medical research by highly successful junior scientists.

Prior to joining the Max Planck Institute for Developmental Biology as the Director of the Department of Microbiome Science in July 2016, Ruth Ley conducted her research at Cornell University and at the Washington University School of Medicine.

Considering the microbiome in medical practice
Hundreds of billions of microbes colonize our bodies - a very personal and individual microbiota, formed and developed from birth throughout our lives. For a long time the human microbiome and its importance to health have been virtually unexplored. However, the progress of molecular biological methods and sequencing techniques in recent years have allowed deep insights into the world of microorganisms. This exciting field of research is expanding at a breathtaking pace, and the results are gradually leading to a rethinking of medical practice. Professor Ruth Ley, Director of the Department of Microbiome Science at the Max Planck Institute for Developmental Biology in Tübingen, is one of the pioneers in microbiome research and has contributed important insights to the current state of knowledge.

Together with other researchers, she showed for the first time that microorganisms in the gut play an important role in our health and metabolism, and that the microbiome, together with other factors, can contribute to obesity, diabetes and chronic autoimmune diseases.

"The human microbiome should definitely be taken into account in the medical treatment of diseases," says Ruth Ley. "Every microbiome is unique and different from person to person. Therefore, I think that good medical practice should be personalized and individual to the patient, "she explains. "The aim should be to include environmental influences that the patient has been exposed to during their lifetime, such as nutrition and other factors that shape the microbiota."


Further Information: 
Jung Foundation for Science and Research: www.jung-stiftung.de

Ruth Ley
E-mail: micro_admin(at)tuebingen.mpg.de

Phone: 07071 601-314
E-Mail: presse-eb(at)tuebingen.mpg.de


About us:

The Max Planck Institute for Developmental Biology, home of the Nobel Laureate Christiane Nüsslein-Volhard, conducts basic research in the fields of biochemistry, genetics and evolutionary biology. It employs about 360 people and is one of four Max Planck Institutes on the Max Planck Campus in Tübingen. The Max Planck Society for the Advancement of Science supports 84 independent institutes.